Miguel Quintela-Fandino

12PUBLICATIONS
77CO-AUTHORS
Bioinformatic methods developmentMolecular targetsPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 10, 2025
A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer.

Luis Manso, Rodrigo Sánchez-Bayona, Juan Antonio Guerra

|Jun 23, 2025
Predicting resistance to chemotherapy using chromosomal instability signatures.

Joe Sneath Thompson, Laura Madrid, Barbara Hernando

|Apr 02, 2025
The impact of a high fat diet and platelet activation on pre-metastatic niche formation.

Marta Hergueta-Redondo, Sara Sánchez-Redondo, Begoña Hurtado

|Sep 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer.

Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora

|Oct 18, 2023
Distribution of PD-L1, TROP2 and HER2- "lowness" in early triple-negative breast cancer: an opportunity for treatment de-escalation.

Maria Jose Bueno, Silvana Mouron, Eduardo Caleiras

Pageof 2